Welcome to our dedicated page for Genworth Finl SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Genworth Financial, Inc. (NYSE: GNW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, annual reports, and quarterly reports filed with the U.S. Securities and Exchange Commission. As a publicly traded holding company with operations in long-term care insurance, life and annuities, and U.S. mortgage insurance through Enact Holdings, Inc. (Nasdaq: ACT), Genworth uses these filings to present detailed financial and segment information.
Investors reviewing GNW SEC filings can examine how Genworth reports results for its Enact, Long-Term Care Insurance, and Life and Annuities segments, along with holding company activities. Filings such as Form 10-K and Form 10-Q typically include discussions of net income, adjusted operating income, segment performance, investment results, statutory capital measures, and risk-based capital ratios for U.S. life insurance subsidiaries. They also describe Genworth’s use of non-GAAP measures, including how adjusted operating income is defined and reconciled to GAAP net income.
Current reports on Form 8-K, such as the filing dated November 5, 2025, document material events including the release of quarterly financial results and the availability of related press releases and financial supplements. These filings often reference exhibits that contain detailed data tables and segment disclosures.
Through Stock Titan, users can follow GNW filings in real time as they are posted to the SEC’s EDGAR system. AI-powered tools summarize lengthy documents, highlight key themes such as capital allocation, share repurchase authorizations, segment trends, and legal or regulatory updates, and help clarify the implications of complex items like liability remeasurement in long-term care, reserve releases in mortgage insurance, or changes in market risk benefits. The filings page can also surface insider transaction reports on Form 4 and proxy-related disclosures when available, giving a fuller view of executive and governance-related information.
Genworth Financial (GNW) filed a Form 4 reporting that its EVP and Chief HR Officer made a charitable gift of company stock. On 11/10/2025, the insider transferred 3,513 shares of Common Stock, coded “G” for gift, at a reported price of $0.
After this transaction, the insider beneficially owns 133,571 shares, listed as direct ownership. The footnote states the shares were gifted to a charitable organization.
Genworth Financial (GNW) received a Schedule 13G from Donald Smith & Co., Inc. and DSCO Value Fund, L.P. reporting beneficial ownership of 24,976,084 shares of GNW common stock, equal to 6.09% of the class, tied to an event date of September 30, 2025.
The filers certify the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Donald Smith & Co., Inc. files as an investment adviser, with economic rights to dividends and sale proceeds residing with its clients. To its knowledge, no single client holds more than 5% of Genworth’s outstanding common stock.
Genworth Financial, Inc. reports solid Q3 2025 results with total revenues of $1.94 billion, slightly above $1.88 billion a year earlier. Net income rose to $147 million from $118 million, and diluted EPS available to common stockholders increased to $0.28 from $0.19.
Total assets reached $88.49 billion and total equity was $9.82 billion as of September 30, 2025. Investment income remained strong at $799 million for the quarter, supported by a $46.11 billion fixed-maturity portfolio. Unrealized investment losses in accumulated other comprehensive income improved versus year-end.
The company continued returning capital to shareholders, repurchasing 19.8 million shares in the first nine months of 2025 at an average price of $7.62 for $153 million. In September 2025 the board authorized a new $350 million buyback program, under which 3.3 million additional shares were repurchased in October, leaving about $325 million capacity.
Genworth Financial, Inc. (GNW) furnished its quarterly materials. The company provided a press release and a financial supplement covering results for the quarter ended September 30, 2025, as Exhibits 99.1 and 99.2.
The information was furnished, not filed, under the Exchange Act and is not subject to Section 18 liabilities, nor incorporated by reference into other filings unless expressly stated.
Genworth Financial Inc. filed a Form 13F reporting its institutional holdings. The report lists 2 holdings with a combined reported market value of $437,197,934. The filing was signed by Darren W. Woodell, Vice President and Controller, on 10-27-2025.
Genworth Financial insider transaction: Rohit Gupta, identified as an officer (President & CEO, Enact) of Genworth Financial, sold 86,406 shares of Genworth common stock on 08/27/2025 at a weighted average sales price of $8.6784 per share. After the sale, Mr. Gupta directly beneficially owned 794,630 shares. In addition, 7,054.809 shares are reported as indirectly owned via a 401(k) plan. The Form 4 was signed by a power of attorney on 08/29/2025. The filer discloses the sale price range ($8.67 to $8.69) and offers to provide a detailed allocation of shares sold at each price on request.
Genworth Financial (GNW) filed an amended Rule 144 notice reporting a proposed sale of 86,406 common shares through J.P. Morgan Securities LLC, with an aggregate market value of $749,140. The shares represent part of the filer’s compensation: 59,080 shares were acquired on 03/25/2024 and 27,326 shares on 03/01/2024. The filing lists the approximate sale date as 08/27/2025 and reports 410,433,925 shares outstanding. The filer certifies no undisclosed material adverse information and provides standard Rule 144 representations.
Genworth Financial (GNW) filed an amended Rule 144 notice reporting a proposed sale of 86,406 common shares through J.P. Morgan Securities LLC, with an aggregate market value of $749,140. The shares represent part of the filer’s compensation: 59,080 shares were acquired on 03/25/2024 and 27,326 shares on 03/01/2024. The filing lists the approximate sale date as 08/27/2025 and reports 410,433,925 shares outstanding. The filer certifies no undisclosed material adverse information and provides standard Rule 144 representations.
Donald Smith & Co., Inc. filed a Schedule 13G reporting aggregate beneficial ownership of 26,198,280 shares of Genworth Financial, Inc. (GNW), representing 6.32% of the class. The filing attributes most holdings to Donald Smith & Co., Inc. with 25,454,680 shares subject to sole voting power and 25,952,450 shares subject to sole dispositive power; DSCO Value Fund, L.P. holds 245,830 shares. The filing identifies Donald Smith & Co., Inc. as an investment adviser organized in Delaware and states the securities are held in the ordinary course of business on behalf of institutional clients, with no single client owning more than 5% of the class. The certification affirms the holdings were not acquired to influence control.